RxDoctor Payments Data

Aaron Tungate

Physician Assistant · Fort Worth, TXNPI 1518911106

Payments from drug & device makers

$585in general payments, 2019–2025

Across 33 payments — averaging $17.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$116
  • Pfizer$106
  • Novartis$76
  • Boehringer Ingelheim$63
  • AstraZeneca$58
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$53
  • plus $114 from 5 others

What the payments were for

  • Food & beverage$57198%
  • Education$142%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$585 in reported general payments places this provider in the 55th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$53,322
Medicare patients
363
Services billed
534

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban335$374,286
JardianceEmpagliflozin84$69,087
EntrestoSacubitril/Valsartan35$51,581
XareltoRivaroxaban32$35,860
Repatha SureclickEvolocumab21$17,897
BrilintaTicagrelor18$10,961
Metoprolol Succinate232$3,315
ClopidogrelClopidogrel Bisulfate147$1,978
Carvedilol242$1,968
Rosuvastatin Calcium116$1,949
Losartan Potassium185$1,499
Amlodipine Besylate226$1,361
Torsemide45$1,344
Potassium Chloride84$1,136
Isosorbide Mononitrate ErIsosorbide Mononitrate78$1,045

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$106$374,286335 claims
Boehringer IngelheimJardiance$63$69,08784 claims
NovartisEntresto$76$51,58135 claims
Johnson & JohnsonXarelto$42$35,86032 claims
AstraZenecaBrilinta$58$10,96118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Fort Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →